Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Questionnaires [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
apnea, obstructive sleep [NCBI] 0.0175677
RA [NCBI] 0.00758344
IS1 [NCBI] 0.0029606
MDD [NCBI] 0.00182278
raynaud disease [NCBI] 0.000785101
panic disorder 2 [NCBI] 0.000785101
KLK3 [NCBI] 0.000772154
neuroticism [NCBI] 0.000729951
VRNI [NCBI] 0.000556552
DYX9 [NCBI] 0.000523057
MYP2 [NCBI] 0.000511063
astigmatism [NCBI] 0.000426125
STUT1 [NCBI] 0.000426125
prosopagnosia, hereditary [NCBI] 0.000364291
CRC [NCBI] 0.000346132
migraine with or without aura, susceptibility to, 1 [NCBI] 0.000310905
vestibulopathy, familial [NCBI] 0.000283778
actinic prurigo [NCBI] 0.000283778
SHBG [NCBI] 0.000271925
QPD [NCBI] 0.000254918
MENOQ1 [NCBI] 0.000254918
GTS [NCBI] 0.000225414
HD [NCBI] 0.000201763
PPR [NCBI] 0.000201233
BULN1 [NCBI] 0.000191742
dermatitis, atopic [NCBI] 0.000191742
sjogren syndrome [NCBI] 0.000175756
novelty seeking personality trait [NCBI] 0.000168918
poland syndrome [NCBI] 0.000161516
PD [NCBI] 0.000147154
coffin-siris syndrome [NCBI] 0.000137179
ETM1 [NCBI] 0.000116037
CJD [NCBI] 0.000108071
abdominal obesity-metabolic syndrome [NCBI] 0.000100229
CDAN2 [NCBI] 0.000100229
MBS [NCBI] 0.000100229
panencephalitis, subacute sclerosing [NCBI] 9.65288e-05
DRD4 [NCBI] 9.18252e-05
APOE [NCBI] 8.79814e-05
alopecia, androgenetic [NCBI] 8.52473e-05
HOA [NCBI] 8.21017e-05
ALD [NCBI] 7.45801e-05
CF [NCBI] 6.75302e-05
SLC6A4 [NCBI] 6.35715e-05
PG [NCBI] 5.86509e-05
musical perfect pitch [NCBI] 5.45643e-05
restless legs syndrome, susceptibility to, 1 [NCBI] 5.36404e-05
myeloproliferative syndrome, transient [NCBI] 5.36404e-05
urinary tract infections, recurrent, susceptibility to [NCBI] 5.11255e-05
lumbar stenosis, familial [NCBI] 5.11255e-05
periodontitis, chronic [NCBI] 5.11255e-05
RNASE3 [NCBI] 4.91052e-05
VEGF [NCBI] 4.68499e-05
TS [NCBI] 4.63272e-05
RTT [NCBI] 4.5617e-05
HMS1 [NCBI] 4.42266e-05
thrombocytopenic purpura, autoimmune [NCBI] 4.19279e-05
COMT [NCBI] 4.05726e-05
temporal arteritis [NCBI] 3.98498e-05
MFS [NCBI] 3.9593e-05
LAM [NCBI] 3.84154e-05
CFH [NCBI] 3.70094e-05
PI [NCBI] 3.63566e-05
SPS [NCBI] 3.53031e-05
asthma-related traits, susceptibility to, 2 [NCBI] 3.4639e-05
varicose veins [NCBI] 3.4639e-05
GNRH1 [NCBI] 3.4111e-05
PTH [NCBI] 3.34661e-05
earlobe crease [NCBI] 2.9979e-05
BWS [NCBI] 2.9463e-05
CD [NCBI] 2.75536e-05
MG [NCBI] 2.72045e-05
DMD [NCBI] 2.53932e-05
CVID [NCBI] 2.44446e-05
twinning, monozygotic [NCBI] 2.33945e-05
chromosome 16p13.3 deletion syndrome [NCBI] 2.33945e-05
sturge-weber syndrome [NCBI] 2.33945e-05
polycystic kidneys [NCBI] 2.30627e-05
NGFB [NCBI] 2.2712e-05
SOD2 [NCBI] 2.19223e-05
SLOS [NCBI] 2.16948e-05
WBS [NCBI] 2.16948e-05
PCD [NCBI] 2.14796e-05
MTRR [NCBI] 2.1381e-05
vitiligo [NCBI] 2.09248e-05
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis [NCBI] 2.09248e-05
rheumatoid arthritis, systemic juvenile [NCBI] 2.09248e-05
VDR [NCBI] 2.05786e-05
MJD [NCBI] 1.94487e-05
tobacco addiction, susceptibility to [NCBI] 1.88161e-05
CVS [NCBI] 1.83105e-05
MIF [NCBI] 1.71464e-05
erythermalgia, primary [NCBI] 1.69876e-05
GBD1 [NCBI] 1.69876e-05
APC [NCBI] 1.66863e-05
ADHD [NCBI] 1.65735e-05
PEE1 [NCBI] 1.62323e-05
CHRNA4 [NCBI] 1.62263e-05
DRD3 [NCBI] 1.595e-05
WFS1 [NCBI] 1.59249e-05
PXE [NCBI] 1.57432e-05
dystrophia myotonica 1 [NCBI] 1.54285e-05
kawasaki disease [NCBI] 1.5383e-05
DGI1 [NCBI] 1.5383e-05
EGFR [NCBI] 1.49887e-05
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 1.49053e-05
GSTM1 [NCBI] 1.45283e-05
MTC [NCBI] 1.39613e-05
GSTP1 [NCBI] 1.39337e-05
melanoma, uveal [NCBI] 1.3835e-05
MAOB [NCBI] 1.33969e-05
d-bifunctional protein deficiency [NCBI] 1.26921e-05
MAFD6 [NCBI] 1.20395e-05
ARMD4 [NCBI] 1.15516e-05
PCNA [NCBI] 1.12053e-05
factor vii deficiency [NCBI] 1.0967e-05
ACHE [NCBI] 1.09038e-05
FH [NCBI] 1.07546e-05
CPI [NCBI] 1.07154e-05
IGF2 [NCBI] 1.0165e-05
BBS [NCBI] 9.82717e-06
AS [NCBI] 9.61889e-06
ELN [NCBI] 9.55331e-06
GPT [NCBI] 9.39131e-06
DSPP [NCBI] 9.23438e-06
GFAP [NCBI] 8.77864e-06
SPCH1 [NCBI] 8.73643e-06
diabetes-deafness syndrome, maternally transmitted [NCBI] 8.73643e-06
BDNF [NCBI] 8.62524e-06
HHT [NCBI] 8.49357e-06
EV [NCBI] 8.4698e-06
SMS [NCBI] 8.24917e-06
LCT [NCBI] 8.01015e-06
PWS [NCBI] 7.72396e-06
homocystinuria [NCBI] 7.55246e-06
CBAVD [NCBI] 7.24812e-06
fabry disease [NCBI] 6.97649e-06
IFNA1 [NCBI] 6.7086e-06
MAOA [NCBI] 6.66356e-06
autonomic control, congenital failure of [NCBI] 6.59543e-06
ORW2 [NCBI] 6.59543e-06
SLE [NCBI] 6.50505e-06
BRCA2 [NCBI] 5.77519e-06
FMF [NCBI] 5.73179e-06
DBA [NCBI] 5.54575e-06
ARMD1 [NCBI] 5.53336e-06
pulmonary fibrosis, idiopathic [NCBI] 5.44341e-06
ALB [NCBI] 5.29325e-06
MECP2 [NCBI] 5.23012e-06
PSNP1 [NCBI] 4.9347e-06
CHNG2 [NCBI] 4.9347e-06
ACADM [NCBI] 4.83635e-06
WHS [NCBI] 4.78319e-06
PSEN1 [NCBI] 4.72286e-06
CRMO [NCBI] 4.46563e-06
hyperglycerolemia [NCBI] 4.46563e-06
PRL [NCBI] 4.22638e-06
GJB2 [NCBI] 4.1541e-06
porphyria variegata [NCBI] 4.11718e-06
OXT [NCBI] 4.10659e-06
MBP [NCBI] 4.06492e-06
AHC [NCBI] 4.03289e-06
MELAS [NCBI] 4.03289e-06
MPO [NCBI] 3.98811e-06
danubian endemic familial nephropathy [NCBI] 3.71091e-06
FAAH [NCBI] 3.7061e-06
COMP [NCBI] 3.68519e-06
MAS [NCBI] 3.37433e-06
phenylketonuria [NCBI] 3.34887e-06
FHM1 [NCBI] 3.26511e-06
BRCA1 [NCBI] 3.22017e-06
RB1 [NCBI] 3.14899e-06
AKR1B1 [NCBI] 2.96158e-06
usher syndrome, type i [NCBI] 2.92522e-06
POF1 [NCBI] 2.92522e-06
CAT [NCBI] 2.8314e-06
SLC6A3 [NCBI] 2.82265e-06
NF1 [NCBI] 2.66417e-06
PNMT [NCBI] 2.40962e-06
STL1 [NCBI] 2.32317e-06
FTD [NCBI] 2.17605e-06
NS1 [NCBI] 2.14622e-06
PSORS1 [NCBI] 2.00726e-06
breast cancer [NCBI] 1.89813e-06
EIG [NCBI] 1.85639e-06
INS [NCBI] 1.84789e-06
APOB [NCBI] 1.8267e-06
LCAT [NCBI] 1.81639e-06
TSD [NCBI] 1.52278e-06
lymphoma, non-hodgkin, familial [NCBI] 1.44222e-06
SPG4 [NCBI] 1.38474e-06
PSACH [NCBI] 1.25095e-06
EPO [NCBI] 1.22585e-06
CADASIL [NCBI] 1.19773e-06
FCAS [NCBI] 1.19773e-06
GAL [NCBI] 1.16957e-06
AVP [NCBI] 1.05207e-06
TG [NCBI] 1.04156e-06
glycogen storage disease ii [NCBI] 9.27402e-07
MB [NCBI] 9.23313e-07
DHFR [NCBI] 9.12276e-07
ACE [NCBI] 7.80232e-07
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 5.60247e-07
FOP [NCBI] 4.97822e-07
G6PD [NCBI] 4.34164e-07
RSTS [NCBI] 3.99274e-07
TNF [NCBI] 3.78047e-07
CRH [NCBI] 3.15713e-07
ACP5 [NCBI] 2.86781e-07
AD [NCBI] 2.62423e-07
CEACAM5 [NCBI] 2.492e-07
LPL [NCBI] 2.16958e-07
MS [NCBI] 2.05811e-07
RP [NCBI] 1.27262e-07
CCK [NCBI] 1.22737e-07
CDLS1 [NCBI] 1.22283e-07
ALGS1 [NCBI] 1.2172e-07
AFP [NCBI] 8.29967e-08
PPARA [NCBI] 6.30759e-08
CNTF [NCBI] 2.77335e-08
AHR [NCBI] 2.57869e-08
galactosemia [NCBI] 2.18122e-08
ARPKD [NCBI] 1.16124e-08
GRA [NCBI] 6.80973e-09
AIS [NCBI] 9.99896e-10



Database Center for Life Science